Johnson & Johnson on X: “#NEWS The U.S. FDA has approved a new subcutaneously administered ther…”

A fast, private reader for public X posts. No account, no tracking, no pop-ups.

PeekX is an independent tool and is not affiliated with, endorsed by or sponsored by X Corp. “X” and “Twitter” are trademarks of their respective owners. We only show posts that their authors made public and never access private or protected accounts. Downloaded media belongs to its creators — please respect their rights.

Johnson & Johnson on X: “#NEWS The U.S. FDA has approved a new subcutaneously administered ther…” | PeekX

Username or post link

Home / @JNJNews / Post

Johnson & Johnson

@JNJNews

#NEWS The U.S. FDA has approved a new subcutaneously administered therapy for the treatment of EGFR-mutated advanced non–small cell lung cancer (NSCLC) in adults.

This treatment option brings us one step closer to delivering more personalized care centered on the patient

0:14

Dec 17, 2025, 11:29 PM UTC

20 24

Download media

Every quality X serves, straight from X's media CDN. No watermark, no wait.

720pBEST

Video · 720×720 · 0:14

540p

Video · 540×540 · 0:14

320p

Video · 320×320 · 0:14

Audio · MP3

0:14 ·

Save & share

Turn this post into a clean image, or copy it as text or Markdown.

Open on X